Evidence map›Paper›PMID 40864743›Full record

ReviewCurrent issues in molecular biology2025

Molecular Mechanisms of Radiation Resistance in Breast Cancer: A Systematic Review of Radiosensitization Strategies.

Emma Mageau, Ronan Derbowka, Noah Dickinson, Natalie Lefort, A Thomas Kovala, Douglas R Boreham, T C Tai, Christopher Thome, Sujeenthar Tharmalingam

Abstract readReview
In one paragraph

Review in Current issues in molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Molecular Pharmacology at the Crossroads of Precision Medicine.Current issues in molecular biology · 2025
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Emma MageauSchool of Natural Sciences, Laurentian University, Sudbury, ON P3E 2C6, Canada.
Ronan DerbowkaSchool of Natural Sciences, Laurentian University, Sudbury, ON P3E 2C6, Canada.ORCID 0009-0007-2753-9515
Noah DickinsonSchool of Natural Sciences, Laurentian University, Sudbury, ON P3E 2C6, Canada.
Natalie LefortUndergraduate Medical Education, NOSM University, 935 Ramsey Lake Rd., Sudbury, ON P3E 2C6, Canada.ORCID 0009-0002-3360-6802
A Thomas KovalaSchool of Natural Sciences, Laurentian University, Sudbury, ON P3E 2C6, Canada.ORCID 0000-0002-2908-5613
Douglas R BorehamSchool of Natural Sciences, Laurentian University, Sudbury, ON P3E 2C6, Canada.
T C TaiSchool of Natural Sciences, Laurentian University, Sudbury, ON P3E 2C6, Canada.
Christopher ThomeSchool of Natural Sciences, Laurentian University, Sudbury, ON P3E 2C6, Canada.ORCID 0000-0002-0160-9657
Sujeenthar TharmalingamSchool of Natural Sciences, Laurentian University, Sudbury, ON P3E 2C6, Canada.

Funding

Canada Graduate Scholarships - Master's program NA1Northern Cancer Foundation NA1Northern Ontario School of Medicine University Faculty Association Research Development Award NA1NSERC Discovery Grant RGPIN-2022-03159Ontario Graduate Scholarship NA1
6 · The paper itself

Abstract

Breast cancer remains one of the most prevalent malignancies worldwide, and radiation therapy is a central component of its management. However, intrinsic or acquired resistance to radiation significantly compromises therapeutic efficacy. This systematic review aimed to identify and evaluate molecular mechanisms and interventions that influence radiation sensitivity in breast cancer models. A comprehensive PubMed search was conducted using the terms "breast cancer" and "radiation resistance" for studies published between 2002 and 2024. Seventy-nine eligible studies were included. The most frequently investigated mechanisms included the dysregulation of the PI3K/AKT/mTOR and MAPK signaling pathways, enhanced DNA damage repair via non-homologous end joining (NHEJ), and the overexpression of cancer stem cell markers such as CD44

Indexed as

breast cancercancer stem cellsCD44+/CD24−/lowDNA damage repairepithelial–mesenchymal transitionimmune modulationlncRNAmicroRNAnon-coding RNAnon-homologous end joiningPI3K/AKT/mTORradiation resistanceradiosensitizationtherapeutic targetstumor microenvironment

Identifiers

PMID40864743
PMCPMC12384436

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.